# Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin

> **NCT01847677** · PHASE2 · TERMINATED · sponsor: **Grupo Español de Investigación en Cáncer de Ovario** · enrollment: 71 (actual)

## Conditions studied

- Cancer, Ovarian

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT01847677
- **Lead sponsor:** Grupo Español de Investigación en Cáncer de Ovario
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05-06
- **Primary completion:** 2015-06-04
- **Final completion:** 2019-05-17
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2020-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847677, "Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01847677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*